A trial exploring the use of a cancer stem cell inhibitor in advanced bowel cancer that terminated early due to futility may have uncovered a potential new treatment target. The double blind randomised phase 3 trial involved 282 patients with advanced bowel cancer recruited from 68 global cancer centres, including Australia. Patients were required to ...
Failed bowel cancer trial finds silver lining
By Nicola Garrett
9 Feb 2018